Key facts
- It has raised $890K; the latest was Seed Round ($890K) in Jan 2026.
- Notable investors include Titan Capital, Aditya Agarwal, PedalStart, V3 Ventures (Brussels).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Be Clinical
- ·The full record, as it builds
Funding rounds
No funding rounds for Be Clinical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Be Clinical
Operator of a science-backed skincare brand intended to target ageing concerns. The company offers various skincare products formulated with medical-grade ingredients and backed by clinical expertise to protect, correct, and optimize skin health at every stage of life through their online platform, enabling users to solve anti-aging problems and improve skin health.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New Delhi, India
- Founded
- 2024
- Website
- be-clinical.com/
- Ownership
- Privately Held (backing)
Be Clinical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Be Clinical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Be Clinical in its N-PORT filings yet. We sweep new filings monthly.